Search
for
Sort by
Research 91–120 of 271
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
- Non-Contraceptive Benefits of Oral Hormonal Contraceptives
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Antiandrogenic progestins for treatment of signs of androgenisation and hormonal contraception
- No. 350-Hirsutism: Evaluation and Treatment
- Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study
- Progestogens with Antiandrogenic Properties
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- Catalytic Antibodies in Norm and Systemic Lupus Erythematosus
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Androgenetic Alopecia: Clinical Aspects and Treatment
- A review of hormonal therapy for female pattern (androgenic) alopecia
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Enhanced therapeutic effects of all-trans retinoic acid nanostructured lipid carrier composite gel drug delivery system for alopecia areata
- A review of hormonal therapy for female pattern (androgenic) alopecia - eScholarship
- Immune Cells in Cutaneous Wound Healing: A Review of Functional Data from Animal Models
- Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women
- Cyproterone acetate for severe hirsutism:results of a double‐blind dose‐ranging study*
- Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study
- A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women
- Comparison of Sequential Cyproterone Acetate/Estrogen Versus Spironolactone/Oral Contraceptive in the Treatment of Hirsutism
- Androgen metabolism in hirsute patients treated with cyproterone acetate
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Presentation of a meningioma in a transwoman after nine years of cyproterone acetate and estradiol intake: case report and literature review
- A systematic review of antiandrogens and feminization in transgender women